NCT00715468View on ClinicalTrials.gov

Prospective, 6 Month, Open Label, Conversion Study From Mycophenolate Mofetil (MMF) to PRMYFORTIC*

CompletedOBSERVATIONAL
Enrollment

59

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

December 31, 2013

Study Completion Date

April 30, 2014

Conditions
Late Complication From Kidney Transplant
Trial Locations (1)

H1T 2M4

Hôpital Maisonneuve-Rosemont, Montreal

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Maisonneuve-Rosemont Hospital

OTHER

NCT00715468 - Prospective, 6 Month, Open Label, Conversion Study From Mycophenolate Mofetil (MMF) to PRMYFORTIC* | Biotech Hunter | Biotech Hunter